May 07, 2021 at 06:57AM
Russia on Thursday authorized the use of a one-shot coronavirus vaccine called “Sputnik Light,” according to the country’s sovereign wealth fund, a move designed to boost vaccine supplies in countries with surging infection rates. The Russian Direct Investment Fund said Sputnik Light, a slimmed-down vaccine developed by Moscow’s Gamaleya Research Institute, has an efficacy rate of 79.4% and would cost less than $10 a dose.
RDIF said the shot, the first component of the country’s flagship two-dose Sputnik V vaccine, is compatible with standard vaccine storage and logistics requirements. It claims one of the potential uses of the single-shot vaccine is for the immunization of a larger number of people in a shorter time frame, noting it can be shipped at speed to a country in the midst of an acute outbreak.
RDIF said late-stage Phase III trials involving 7,000 people were underway in Russia, the United Arab Emirates and Ghana, among other countries. Interim results were expected later this month. Phase I and Phase II results of the single-dose Sputnik Light vaccine found the shot demonstrated safety for all subjects and no serious adverse events were registered, it said.
Russia authorizes use of ‘Sputnik Light,’ a one-shot Covid vaccine it says is 79% effective, CNBC, May 7
From: The FxPro News Team https://fxpro.news/market-overview/russia-authorizes-use-of-sputnik-light-a-one-shot-covid-vaccine-it-says-is-79-effective-20210507/
Selected by fonecable.com
Search Web: Russia authorizes use of ‘Sputnik Light,’ a one-shot Covid vaccine it says is 79% effective
- Australian Dollar Forecast: Major AUD/NZD Bottom May Soon Be Approaching
- British Pound Slips After Data, Still Tied to Range. Can GBP/USD Break Out Ahead of FOMC?
- How to Research Stocks: A Step by Step Guide
- Gold Price Outlook Turns to UofM Sentiment as US Dollar, Treasury Yields Rally
- New Zealand Dollar Outlook: NZD/USD Drops on US Dollar Bids, Wall Street Losses